The effects of amantadine on traumatic brain injury outcome: a double-blind, randomized, controlled, clinical trial

References

• Mathers C, Fat DM, Boerma JT; World Health Organization. The global burden of disease: 2004 update. Geneva, Switzerland: World Health Organization; 2008.
   Google Scholar
• Chew E, Zafonte RD. Pharmacological management of neurobehavioral disorders following traumatic brain injury–a state-of-the-art review. J Rehabil Res Dev. 2009;46(6):851–79. doi:10.1682/JRRD.2008.09.0120.
   PubMed Web of Science ®Google Scholar
• Leone H, Polsonetti BW. Amantadine for traumatic brain injury: does it improve cognition and reduce agitation? J Clin Pharm Ther. 2005;30(2):101–04. doi:10.1111/j.1365-2710.2005.00628.x.
   PubMed Web of Science ®Google Scholar
• Roozenbeek B, Maas AI, Menon DK. Changing patterns in the epidemiology of traumatic brain injury. Nat Rev Neurol. 2013;9(4):231–36. doi:10.1038/nrneurol.2013.22.
   PubMed Web of Science ®Google Scholar
• Levin HS, Saydjari C, Eisenberg HM, Foulkes M, Marshall LF, Ruff RM, Jane JA, Marmarou A. Vegetative state after closed-head injury. A traumatic coma data bank report. Arch Neurol. 1991;48(6):580–85. doi:10.1001/archneur.1991.00530180032013.
   PubMed Web of Science ®Google Scholar
• Andersson EE, Bedics BK, Falkmer T. Mild traumatic brain injuries: a 10-year follow-up. J Rehabil Med. 2011;43(4):323–29. doi:10.2340/16501977-0666.
   PubMed Web of Science ®Google Scholar
• Brown JI, Baker AJ, Konasiewicz SJ, Moulton RJ. Clinical significance of CSF glutamate concentrations following severe traumatic brain injury in humans. J Neurotrauma. 1998;15(4):253–63. doi:10.1089/neu.1998.15.253.
   PubMed Web of Science ®Google Scholar
• Guerriero RM, Giza CC, Rotenberg A. Glutamate and GABA imbalance following traumatic brain injury. Curr Neurol Neurosci Rep. 2015;15(5):27. doi:10.1007/s11910-015-0545-1.
   PubMed Web of Science ®Google Scholar
• Shohami E, Biegon A. Novel approach to the role of NMDA receptors in traumatic brain injury. CNS Neurol Disord Drug Targets. 2014;13(4):567–73. CNSNDDT-EPUB-57030 [pii]. doi:10.2174/18715273113126660196.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Yamada M, Suhara T. Functional significance of central D1 receptors in cognition: beyond working memory. J Cereb Blood Flow Metab. 2012;32(7):1248–58. doi:10.1038/jcbfm.2011.194.
   PubMed Web of Science ®Google Scholar
• Bales JW, Kline AE, Wagner AK, Dixon CE. Targeting dopamine in acute traumatic brain injury. Open Drug Discov J. 2010;2:119–28.
   PubMedGoogle Scholar
• Sawyer E, Mauro LS, Ohlinger MJ. Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother. 2008;42(2):247–52. doi:10.1345/aph.1K284.
   PubMed Web of Science ®Google Scholar
• Bullock R. Opportunities for neuroprotective drugs in clinical management of head injury. J Emerg Med. 1993;11(Suppl 1):23–30.
   PubMedGoogle Scholar
• Chandler MC, Barnhill JL, Gualtieri CT. Amantadine for the agitated head-injury patient. Brain Inj. 1988;2(4):309–11. doi:10.3109/02699058809150901.
   PubMedGoogle Scholar
• Saniova B, Drobny M, Kneslova L, Minarik M. The outcome of patients with severe head injuries treated with amantadine sulphate. J Neural Transm. 2004;111(4):511–14. doi:10.1007/s00702-004-0112-4.
   PubMed Web of Science ®Google Scholar
• Gualtieri T, Chandler M, Coons TB, Brown LT. Amantadine: a new clinical profile for traumatic brain injury. Clin Neuropharmacol. 1989;12(4):258–70. doi:10.1097/00002826-198908000-00003.
   PubMed Web of Science ®Google Scholar
• Giacino JT, Whyte J, Bagiella E, Kalmar K, Childs N, Khademi A, Eifert B, Long D, Katz DI, Cho S, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012;366(9):819–26. doi:10.1056/NEJMoa1102609.
   PubMed Web of Science ®Google Scholar
• Hammond FM, Bickett AK, Norton JH, Pershad R. Effectiveness of amantadine hydrochloride in the reduction of chronic traumatic brain injury irritability and aggression. J Head Trauma Rehabil. 2014;29(5):391–99. doi:10.1097/01.HTR.0000438116.56228.de.
   PubMed Web of Science ®Google Scholar
• Hammond FM, Sherer M, Malec JF, Zafonte RD, Whitney M, Bell K, Dikmen S, Bogner J, Mysiw J, Pershad R. Amantadine effect on perceptions of irritability after traumatic brain injury: results of the amantadine irritability multisite study. J Neurotrauma. 2015;32(16):1230–38. doi:10.1089/neu.2014.3803.
   PubMed Web of Science ®Google Scholar
• Meythaler JM, Brunner RC, Johnson A, Novack TA. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil. 2002;17(4):300–13. doi:10.1097/00001199-200208000-00004.
   PubMed Web of Science ®Google Scholar
• Schneider WN, Drew-Cates J, Wong TM, Dombovy ML. Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study. Brain Inj. 1999;13(11):863–72. doi:10.1097/PHM.0b013e3181a5ade3.
   PubMed Web of Science ®Google Scholar
• McMahon MA, Vargus-Adams JN, Michaud LJ, Bean J. Effects of amantadine in children with impaired consciousness caused by acquired brain injury: a pilot study. Am J Phys Med Rehabil. 2009;88(7):525–32. doi:10.1097/PHM.0b013e3181a5ade3.
   PubMed Web of Science ®Google Scholar
• Patrick PD, Blackman JA, Mabry JL, Buck ML, Gurka MJ, Conaway MR. Dopamine agonist therapy in low-response children following traumatic brain injury. J Child Neurol. 2006;21(10):879–85. doi:10.1177/08830738060210100901.
   PubMed Web of Science ®Google Scholar
• Beers SR, Skold A, Dixon CE, Adelson PD. Neurobehavioral effects of amantadine after pediatric traumatic brain injury: a preliminary report. J Head Trauma Rehabil. 2005;20(5):450–63. 00001199-200509000-00006 [pii]. doi:10.1097/00001199-200509000-00006.
   PubMed Web of Science ®Google Scholar
• Muzi F, Orlando G, Ielpo B, Anselmo A, Sabato Ceraldi S, De Liguori Carino N, Manzia T, D’Andria D, Tariciotti L, Angelico M, et al. Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. Transplant Proc. 2005;37(4):1705–07. doi:10.1016/j.transproceed.2005.03.077.
   PubMed Web of Science ®Google Scholar
• Symmetrel, amantadine. Product information. Wilmington, DE: DuPont Pharmaceuticals; 2001.
   Google Scholar
• Frenete AJ, Kanji S, Rees L, Williamson DR, Perreault MM, Turgeon AF, Bernard F, Fergusson DA. Efficacy and safety of dopamine agonists in traumatic brain injury: a systematic review of randomized controlled trials. J Neurotrauma. 2012;29(1):1–18. doi:10.1089/neu.2011.1812.
   PubMed Web of Science ®Google Scholar